Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 4
2(40.0%)
5Total
N/A(3)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02756000Not ApplicableCompleted

Timing of Complete Revascularization for Multivessel Coronary Artery Disease in STEMI

Role: lead

NCT02107144Phase 4Completed

The ImPact of Trimetazidine on MicrOcirculation After Stenting for Stable Coronary Artery Disease

Role: lead

NCT01943643Not ApplicableCompleted

Multislice CT Angiography of Coronary Bifurcations and Outcomes After Intervention

Role: lead

NCT04432610Phase 4Withdrawn

Echocardiographic Study of a Single Dose Bisoprolol Versus Nebivolol in Healthy Subjects

Role: lead

NCT02800967Not ApplicableUnknown

The Effects of Aronia Juice Polyphenols on Cardiovascular Disease Risk

Role: collaborator

All 5 trials loaded